Synthesis and Characterization of Stable Monodisperse Silica Nanoparticle Sols for in Vitro Cytotoxicity Testing

LCJ Thomassen, A Aerts, V Rabolli, D Lison… - Langmuir, 2010 - ACS Publications
For the investigation of the interaction of nanoparticles with biomolecules, cells, organs, and
animal models there is a need for well-characterized nanoparticle suspensions. In this paper …

The cytotoxic activity of amorphous silica nanoparticles is mainly influenced by surface area and not by aggregation

V Rabolli, LCJ Thomassen, F Uwambayinema… - Toxicology letters, 2011 - Elsevier
The aggregation state of NP has been a significant source of difficulty for assessing their
toxic activity and great efforts have been done to reduce aggregation of and/or to disperse …

Comparative safety evaluation of silica-based particles

H Kettiger, DS Karaman, L Schiesser, JM Rosenholm… - Toxicology in Vitro, 2015 - Elsevier
Abstract Purpose Silica nanoparticles (SNPs) are increasingly used as drug delivery
systems (DDS) and for biomedical imaging. Therapeutic and diagnostic agents can be …

Characterisation of silica nanoparticles prior to in vitro studies: from primary particles to agglomerates

G Orts-Gil, K Natte, D Drescher, H Bresch… - Journal of Nanoparticle …, 2011 - Springer
The size, surface charge and agglomeration state of nanoparticles under physiological
conditions are fundamental parameters to be determined prior to their application in …

Toxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects

D Drescher, G Orts-Gil, G Laube, K Natte… - Analytical and …, 2011 - Springer
Cell cultures form the basis of most biological assays conducted to assess the cytotoxicity of
nanomaterials. Since the molecular environment of nanoparticles exerts influence on their …

[HTML][HTML] Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers

TI Janjua, Y Cao, F Kleitz, M Linden, C Yu… - Advanced Drug Delivery …, 2023 - Elsevier
Silica nanoparticles (SNP) have gained tremendous attention in the recent decades. They
have been used in many different biomedical fields including diagnosis, biosensing and …

Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation

E Izak-Nau, M Voetz, S Eiden, A Duschl… - Particle and fibre …, 2013 - Springer
Background Many toxicological studies on silica nanoparticles (NPs) have been reported,
however, the literature often shows various conclusions concerning the same material. This …

[HTML][HTML] In vitro and in vivo evaluation of degradation, toxicity, biodistribution, and clearance of silica nanoparticles as a function of size, porosity, density, and …

SPH Moghaddam, R Mohammadpour… - Journal of controlled …, 2019 - ncbi.nlm.nih.gov
Abstract Silica nanoparticles (SiO 2 NPs) have potential utility in controlled release. Despite
significant research in this area, there is a gap in the understanding of the correlation …

Quantification of internalized silica nanoparticles via STED microscopy

H Peuschel, T Ruckelshausen… - BioMed research …, 2015 - Wiley Online Library
The development of safe engineered nanoparticles (NPs) requires a detailed understanding
of their interaction mechanisms on a cellular level. Therefore, quantification of NP …

Toxicity of silica nanoparticles depends on size, dose, and cell type

IY Kim, E Joachim, H Choi, K Kim - … : Nanotechnology, Biology and Medicine, 2015 - Elsevier
Monodisperse spherical silica nanoparticles (SNPs) with diameters of 20–200 nm were
employed to study size, dose, and cell-type dependent cytotoxicity in A549 and HepG2 …